Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01518777 · ClinicalTrials.gov registry record · NA
Reducing Radioisotope Dose: the Half-Dose CZT Study
A NA study of Coronary Artery Disease, sponsored by S.M.Chang, MD.
- Completed
- Registry status
- NA
- Development phase
- 74
- Enrollment target
- 1
- Study location
NCT01518777: Completed NA study of Coronary Artery Disease, sponsored by S.M.Chang, MD.
NCT01518777 is a NA study of Coronary Artery Disease that has completed, run by S.M.Chang, MD. The registered enrollment target is 74 participants, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01518777, a NA study of Coronary Artery Disease, has completed, sponsored by S.M.Chang, MD.
- COMPLETED
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot study to see whether cardiac imaging can be performed using half the standard dose of radioisotope.
Conditions Studied
Interventions
- OTHER Half-dose isotope for NuclearStressTest
Study Locations (1)
Texas
- Houston Methodist Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2012-01 |
| Est. Completion | 2016-12-16 |
| Phase | NA |
What the finished NCT01518777 record still lists
NCT01518777 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which Half-dose isotope for NuclearStressTest is the first listed.
NCT01518777 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT01518777 about?
NCT01518777 is a clinical study titled "Reducing Radioisotope Dose: the Half-Dose CZT Study". This is a pilot study to see whether cardiac imaging can be performed using half the standard dose of radioisotope.
What is the current status of trial NCT01518777?
This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2012-01. Estimated completion is 2016-12-16.
What conditions does trial NCT01518777 study?
This clinical trial studies the following conditions: Coronary Artery Disease.
What interventions are being tested in trial NCT01518777?
The interventions under investigation include: Half-dose isotope for NuclearStressTest (OTHER).
Who is sponsoring clinical trial NCT01518777?
This trial is sponsored by S.M.Chang, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01518777 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01518777's enrollment target sits among peer trials
74 163rd of 219 higher than 57 of 219 other Coronary Artery Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Coronary Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
RECRUITING · NA
-
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
RECRUITING · NA
-
Intravascular Lithotripsy With or Without Rotational Atherectomy for Coronary Calcified Nodule Treatment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422731 · 74 participants · Early Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- NCT03804853 · 74 participants · NA
Rehabilitation Following Reverse Total Shoulder Arthroplasty
- NCT04065776 · 74 participants · NA
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- NCT04771156 · 74 participants · Phase 4
Ketorolac in Palatoplasty
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia